ARCHIVES

Abstracts Of Papers From Gynecologic Oncology Conference

This article is from The Cancer Letter archive.

Vol. 01 No. 42 | October 17, 1975

Download PDF Visit The Full Archive

Related Articles

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012

News Organizations Protest invitation-Only Press Conferences, Exclusion of Reporters

May 20, 1994

Two Phase II Studies of Ibrutinib Deliver High Response Rates

December 27, 2013

NCI Programs: Seven Win Awards For Cancer Genetics Network, Informatics

July 31, 1998

NS Sponsors Workshop On Prevention For Three Minority Groups

July 1, 1988

Clinical Trials Issues: Maryland Law Mandates Insurance Coverage Of Patient Care Costs In Clinical Trials

July 3, 1998